Maternal and perinatal outcomes of eclampsia: Nova Scotia, 1981-2000.
D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004461:Eclampsia / Q000188:drug therapy / Q000453:epidemiology* / Q000401:mortality; D005260:Female; D017359:HELLP Syndrome / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D008278:Magnesium Sulfate / Q000627:therapeutic use; D008428:Maternal Mortality; D009674:Nova Scotia / Q000453:epidemiology; D011225:Pre-Eclampsia / Q000188:drug therapy / Q000453:epidemiology / Q000401:mortality; D011247:Pregnancy; D011256:Pregnancy Outcome / Q000453:epidemiology*; D015995:Prevalence; D012189:Retrospective Studies; D012640:Seizures / Q000188:drug therapy / Q000209:etiology
D000927:Anticonvulsants; D000959:Antihypertensive Agents; D008278:Magnesium Sulfate